Preeclampsia, Medications, Magnesium Sulfate

Key Lab Values in Preeclampsia
  1. Platelets

    • Commonly less than 100×103/μL100\times 10^3/\mu L with preeclampsia and HELLP syndrome.

    • Impacts epidural placement and the ability to clot, necessitating close monitoring.

  2. Liver Function Tests (LFTs)

    • Levels (e.g., AST, ALT) increase significantly with preeclampsia and even more so with HELLP syndrome.

    • Indicate impaired liver function.

  3. Urine Protein

    • A 24-hour urine collection showing 300mg300 mg or more of protein is indicative of preeclampsia.

  4. Protein-Creatinine Ratio

    • A ratio greater than 0.30.3 is a concern.

Managing Patients with Preeclampsia
  1. Environmental Modifications

    • Maintain low lights and decrease external stimuli (e.g., restrict family, minimize staff interruptions, encourage turning off phones/TVs).

    • Raise and pad side rails as a safety measure to protect the patient in case of seizure activity (preeclampsia can progress to eclampsia).

    • Ensure an airway is available at the bedside.

  2. Notifications

    • Immediately notify the neonatologist and NICU if the baby is preterm, as delivery may become imminent.

  3. Calcium Gluconate Availability

    • Calcium gluconate, the antidote for magnesium toxicity, must be readily available on the unit, not just in the pharmacy.

Medications for Preeclampsia

Antihypertensives

  1. Oral Nifedipine

    • Effective for treating preeclampsia.

    • As effective as IV Labetalol and Hydralazine.

    • Useful for newly admitted patients without IV access to initiate blood pressure control.

  2. Labetalol

    • Primary IV medication for severe maternal hypertension (BP160/110mmHgBP\ge 160/110 mmHg or 160/105mmHg160/105 mmHg).

    • Algorithm for Severe Elevations (e.g., two severe elevations within 15 minutes):

      • First Dose: 20mgIV20 mg IV push slowly over 2 minutes.

      • Recheck BP in 10 minutes.

      • Second Dose (if BP still high): 40mgIV40 mg IV push slowly over 2 minutes.

      • Recheck BP in 10 minutes.

      • Third Dose (if BP still high): 80mgIV80 mg IV push slowly over 2 minutes.

      • This is known as the "double-double rule" (20,40,80mg20, 40, 80 mg).

    • Non-response: If blood pressure remains elevated after the third dose, generally switch to an alternative antihypertensive (e.g., Hydralazine or Oral Nifedipine).

    • Cumulative Dose: Maximum IV dose is 300mg300 mg in 24 hours.

    • Contraindications: Low pulse, active asthma, heart failure, or heart disease.

  3. Hydralazine

    • Another commonly used IV antihypertensive.

Magnesium Sulfate (MgSO4)

  • Purpose: Not an antihypertensive; decreases central nervous system (CNS) irritation to prevent and treat seizures (eclampsia).

  • Nomenclature: Must not be abbreviated (e.g., "MagSafeit") to avoid confusion with morphine sulfate.

  • Preparation and Administration:

    • Typically supplied by pharmacy as 40grams40 grams in 1L1 L of Lactated Ringer's (LR) or 20grams20 grams in 500mLLR500 mL LR (same concentration).

    • Always administered via an IV pump.

    • Administer as an IV piggyback, connected to the port closest to the IV hub.

  • Dosing:

    • Bolus Dose: Commonly 4grams4 grams infused over 30 minutes (specific dose and duration may vary per protocol/provider).

    • Maintenance Dose: Commonly 2grams/hour2 grams/hour (rate may vary).

  • Client and Family Education:

    • Explain the medication's purpose and expected side effects.

    • Instruct about signs and symptoms of toxicity to report.

    • Explain the nature and frequency of continuous assessments during therapy.

  • Common Side Effects: Drowsiness, fatigue, flushing, overwhelming warmth, and a burning sensation at the IV site (especially during the bolus).

  • Signs of Toxicity: Hypoactive or absent deep tendon reflexes, decreased level of consciousness (drowsiness to unresponsiveness), and decreased respiratory rate.

  • Priority Action for Toxicity:

    1. Immediately STOP the magnesium sulfate infusion.

    2. Call for assistance (e.g., charge nurse, rapid response team).

    3. Ensure oxygen is available and obtain a fresh set of vital signs.

    4. Administer Calcium Gluconate (antidote).

  • Administration Requirements:

    • Must be administered on a pump, IV piggyback, and connected to the closest port to the hub.

    • Requires a 2-RN review to verify the order and calculations.

Magnesium Sulfate Calculations

Given: Order for a 4gram4 gram loading dose, 2grams/hour2 grams/hour maintenance, and a total IV fluid limit of 125mL/hour125 mL/hour. Pharmacy provides a 1L(1000mL)1 L (1000 mL) bag containing 40grams40 grams of magnesium sulfate.

  1. Loading Dose Rate Calculation

    • Volume to be infused for loading dose: (4 g desired/40 g on hand)×1000 mL=100 mL(4 \text{ g desired} / 40 \text{ g on hand}) \times 1000 \text{ mL} = 100 \text{ mL}

    • Pump rate for loading dose (over 30 minutes): 100 mL/0.5 hours=200 mL/hour100 \text{ mL} / 0.5 \text{ hours} = 200 \text{ mL/hour}

  2. Maintenance Dose Rate Calculation

    • Volume containing 2 grams: (2 g desired/40 g on hand)×1000 mL=50 mL(2 \text{ g desired} / 40 \text{ g on hand}) \times 1000 \text{ mL} = 50 \text{ mL}

    • Pump rate for maintenance dose: 50 mL/hour50 \text{ mL/hour} (since it is a 2grams/hour2 grams/hour order).

  3. Mainline IV Fluid Rate

    • Total desired hourly IV fluid: 125 mL/hour125 \text{ mL/hour}

    • Subtract magnesium maintenance rate: 125 mL/hour50 mL/hour (for magnesium)=75 mL/hour125 \text{ mL/hour} - 50 \text{ mL/hour (for magnesium)} = 75 \text{ mL/hour}

    • The mainline IV should be set at 75 mL/hour75 \text{ mL/hour}, and all fluids (except perhaps ice chips) should be on a pump, with strict intake and output (I&O) monitoring.

Nursing Actions for Quality Patient Outcomes

Appropriate nursing actions for patients with preeclampsia to ensure positive outcomes include:

  1. Monitoring IV fluids and meticulously assessing intake and output (I&O).

  2. Reporting any changes in vital signs, patient behavior, or level of consciousness promptly.

  3. Maintaining bed rest, especially for patients on magnesium sulfate, due to its muscle relaxant effects and potential for weakness.